Delivery Order SPE2DR25D3303-SPE2DR26F65B7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,224.36 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of January 6, 2026. This non-set-aside contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,562.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of December 12, 2025. This non-set-aside delivery order represents a single pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,210.56 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.06 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,339.76 for Albuterol HFA 90 mcg inhalers (8.5 gm) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,630.77 to AmerisourceBergen Drug Corp for Albuterol HFA 90MCG inhalers. This is a firm fixed price delivery order under a non-set-aside competitive procurement, with a completion deadline of December 31, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will serve as the place of performance for this order. The contract represents a continuation of the company's significant role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,083.15 to AmerisourceBergen Drug Corp for Albuterol HFA 90 micrograms inhaler 8.5 grams on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitive award utilized firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,400.36 to AmerisourceBergen Drug Corp for Albuterol HFA 90 mcg inhalers (8.5 grams) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 gm) valued at $1,241.52. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and carries an ultimate completion date of December 5, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F65B7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,311.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 6.7 gram units. This firm fixed-price delivery order was competitively awarded without set-aside designation on January 7, 2026, with an ultimate completion date of January 8, 2026. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, medical supplies, vaccines, and related healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and other federal medical institutions. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement is reflected in its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/6/26 |